C. Roux
Orthopedics and Sports Medicine · Osteoporosis International · 2000–2018
A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Orthopedics and Sports Medicine — 18 citations into it
Whom C. Roux trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Chris Cooper (in Orthopedics and Sports Medicine)
Papers from C. Roux's perspective
Ordered by how strongly the researchers C. Roux trusts endorse each paper. Same corpus, a different order for every researcher.
- Use of Oral Corticosteroids and Risk of Fractures (Journal of Bone and Mineral Research)
- Denosumab for prevention of fractures in postmenopausal women with osteoporosis. (New England Journal of Medicine)
- An estimate of the worldwide prevalence and disability associated with osteoporotic fractures (Osteoporosis International)
- An estimate of the worldwide prevalence, mortality and disability associated with hip fracture
- Mortality after osteoporotic fractures (Osteoporosis International)
- Early mortality after hip fracture: is delay before surgery important? (Journal of Bone and Joint Surgery. American volume)
- Association of timing of surgery for hip fracture and patient outcomes. (Journal of the American Medical Association (JAMA))
- Zoledronic acid and clinical fractures and mortality after hip fracture. (New England Journal of Medicine)
- Bone resorption by osteoclasts. (Science)
- Denosumab in postmenopausal women with low bone mineral density. (New England Journal of Medicine)
Their papers
- Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis (2000) — 1,657 citations
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo‐Controlled FREEDOM Trial and Its Extension (2018) — 626 citations
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. (2017) — 792 citations
- Glucocorticoid-induced osteoporosis (2015) — 750 citations
- Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. (2001) — 1,607 citations